Every 23 seconds, someone in the United States is diagnosed with diabetes, a stark reminder of the growing need for effective and accessible diabetes care solutions. For individuals and families grappling with this condition, understanding resources like the Abbott Patient Assistance Program becomes crucial. Like actress Sherri Shepherd, who faced a personal wake-up call regarding her diabetes management, many are seeking better ways to navigate this challenging health journey.
Shepherd’s story highlights a pivotal moment: her son’s poignant question about who would protect him if she were gone. This resonated deeply, pushing her to actively seek support and better manage her health. Her journey underscores the importance of continuous glucose monitoring (CGM) systems, particularly Abbott’s FreeStyle Libre technology, in empowering individuals to take control of their diabetes.
Continuous glucose monitoring offers a transformative approach to diabetes management. Instead of relying on infrequent finger prick tests, CGM systems provide real-time glucose level readings, offering a dynamic view of glucose trends throughout the day and night. This constant stream of data equips patients with the knowledge to make informed decisions about diet, exercise, and medication, helping to prevent dangerous glucose spikes and mitigate long-term diabetes complications. As Shepherd emphasizes, knowing your numbers in real-time is power.
Despite the proven benefits of CGM, remarkably only a small fraction – around 1% – of people with diabetes worldwide currently utilize this life-changing technology. This gap highlights a critical need to improve access and awareness of CGM systems and related patient assistance programs that can make these technologies more affordable and accessible.
Abbott is actively working to bridge this gap. Recognizing the urgency, Abbott has launched initiatives to raise awareness about diabetes and the benefits of CGM, particularly through their FreeStyle Libre portfolio. Their commitment extends to supporting organizations like the American Diabetes Association, demonstrated through donation campaigns aimed at expanding diabetes education and access to care.
One such initiative, highlighted during November, including World Diabetes Day on November 14th, involves a donation to the American Diabetes Association for every visit to their “Countdown at a Crossroads” webpage. This campaign symbolizes the critical juncture many individuals face upon a diabetes diagnosis and Abbott’s aim to provide a path forward through technology and support.
Abbott’s FreeStyle Libre 3 system represents a significant advancement in CGM technology. Approved for use in individuals with diabetes aged four years and older, including pregnant women, it is recognized as the most accurate 14-day CGM available. Its minute-by-minute glucose readings are conveniently sent directly to a smartphone, providing continuous insights without the need for routine scanning. Furthermore, its discreet size, comparable to two stacked pennies, enhances user comfort and convenience.
To further promote access to CGM technology, Abbott offers programs like MyFreeStyle, a diabetes education and support platform. Eligible individuals can even receive a free two-week trial of a CGM sensor through this program, allowing them to experience the benefits of FreeStyle Libre firsthand and determine if CGM is the right approach for their diabetes management. This trial program is a valuable opportunity to understand the practical advantages of continuous glucose monitoring in daily life.
The fact remains that the vast majority of people with diabetes are not yet benefiting from CGM technology. Through patient assistance initiatives, awareness campaigns, and innovative technologies like FreeStyle Libre, Abbott is striving to change this landscape. By providing education, support, and access to advanced diabetes management tools, Abbott is empowering individuals to proactively manage their health and improve their quality of life.
For more information about continuous glucose monitoring and Abbott’s initiatives, visit the Countdown at a Crossroads page. Explore the resources available and discuss with your healthcare provider how CGM technology and patient assistance programs can support your diabetes care journey.
